The effect of membrane biocompatibility on plasma β2-microglobulin levels in chronic hemodialysis patients

Journal of the American Society of Nephrology

Volumn 7, Issue 3, 1996, Pages 472-478

  Hakim, Raymond M ^a   Wingard, Rebecca L ^a   Husni, Leigh ^b   Parker, Robert A ^a   Parker III, Tom F ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Dallas Nephrology Associates   (United States)

Author keywords

Carpal tunnel syndrome; Dialysis; Reactive oxygen species; 2 microglobulin polymerization; 2 microglobulin synthesis

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029919234     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v73472     Document Type: Article

References (36)

1. 2-microglobulin. J Exp Med 1973;138: 1608-1612.
2. 2-microglobulin in some plasma membranes and biological fluids. Scand J Immunol 1980;11:341-351.
3. Stone WJ, Hakim RM: Beta-2 microglobulin amyloidosis in long-term dialysis patients. Am J Nephrol 1989;9: 177-183.
4. 2-microglobulin: The constant chain of HLA-antigens. Eur J Clin Invest 1980;10:293-300.
5. 2-microglobulin: Its significance in the evaluation of renal function. Kidney Int 1987;32:635-641.
6. Stein G, Schneider A, Thoss K, et al.: Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients. Nephrol Dial Transplant 1991; 6:57-61.
7. 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986;314:585-586.
8. 2-microglobulin deposition in bone in chronic renal failure. Kidney Int 1991;39:990-995.
9. 2-microglobulin. Biochem Biophys Res Commun 1985;129:701-706.
10. Gorevic PD, Stone TT, Stone WJ, Diraimondo CR, Prelli FC, Frangione B: Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest 1985;76:2425-2429.
11. Bardin T, Zingraff J, Kuntz D, Drucke T: Dialysis related amyloidosis. Nephrol Dial Transplant 1986;1:151-154.
12. 2-microglobulin a mediator of bone disease? Kidney Int 1995;47:1-6.
13. 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Clin Nephrol 1994;42[Suppl 1]:S52-S56.
14. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart L, and The Working Party on Dialysis Amyloidosis: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991;39:1012-1019.
15. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F: Carpal tunnel syndrome and type of dialysis membrane. Br J Med 1989;298:867-868.
16. Miura Y, Ishiyama T, Inomata A, et al.: Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 1992;60: 268-273.
17. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;44:484-494.
18. 2-microglobulin concentration in dialysis patients: Importance of intrinsic renal function. J Lab Clin Med 1994; 123:495-505.
19. 2-microglobulin synthesis by activated late complement components. Am J Kidney Dis 1993;21:394-399.
20. 2-microglobulin synthesis in lymphocytes after exposure to cuprophan dialyzer membranes. Kidney Int 1991;40:285-290.
21. 2-microglobulin production and cellular expression. Kidney Int 1990;38:962-968.
22. Heonich NA, Stenton CS, Woffindin C, et al.: Comparison of membranes used in the treatment of end-stage renal failure. Kidney Int 1988;33[Suppl 24]:S44-S48.
23. Deppisch R, Ritz E, Hansch M, Schols M, Rauterberg E: Bioincompatibility - Perspectives in 1993. Kidney Int 1994;45[Suppl 44]:S77-S84.
24. Malo-Martin A, Castillo D, Castro M, et al.: Biocompatibility of dialysis membranes: A comparative study. Nephrol Dial Transplant 1991;6:55-58.
25. 2-microglobulin removal is possible with low flux membranes [Abstract]. J Am Soc Nephrol 1995;6:505A.
26. Memoli B, Libetta C, Rampino T, et al.: Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1991;42:320-326.
27. 2 microglobulin kinetics during cuprophan hemodialysis: A hypothesis. Int J Artif Organs 1989;12:638-641.
28. 2-microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med 1991;118:153-165.
29. 2-microglobulin: Equilibrium and kinetic characterization. Kidney Int 1994;46:1140-1146.
30. 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. Nephrol Dial Transplant 1989;4: 653-657.
31. 2-microglobulin kinetics during hemofiltration. Nephrol Dial Transplant 1989;3:784-789.
32. Blumberg A, Buergi W: Behavior of β2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and CAPD. Clin Nephrol 1987; 27:245-249.
33. Zingraff J, Beyne P, Urena ME: Influence of hemodialysis membranes on β2-microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Transplant 1988;3:284-290.
34. 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991;39:909-919.
35. 2-microglobulin [Abstract]. J Am Soc Nephrol 1991;2: 356A.
36. Linke RP, Hampl H, Lobeck H, et al.: Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 1989;36:675-681.